Eisai has invested in 3 companies and its latest investment was C2N Diagnostics on Mar 05, 2024
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
C2N Diagnostics is a Missouri-based molecular diagnostics company that develops blood test kits for the early diagnosis and treatment of Alzheimer’s diseases.
$15M
Mar 05, 2024
-
Ractigen Therapeutics is a Canada-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of genetic diseases.
$30M
Jan 26, 2022
-
Neuroglee is a biotechnology company that develops and commercialize software to digital therapeutics for the treatment of neurodegenerative diseases.
$2.3M
Dec 01, 2020
-
Frequently Asked Questions about Eisai
What is Eisai investing in?
Eisai has invested in 3 companies including C2N Diagnostics, Ractigen Therapeutics and Neuroglee
What company did Eisai invest in?
Eisai invested in a total 3 companies including C2N Diagnostics, Ractigen Therapeutics and Neuroglee
What are the top 3 investments by Eisai?
The top companies in which Eisai invested are C2N Diagnostics, Ractigen Therapeutics and Neuroglee
